Large-cap Health Care company Zimmer Biomet has logged a 1.5% change today on a trading volume of 193,154. The average volume for the stock is 1,515,996.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Based in Warsaw, United States the company has 18,000 full time employees and a market cap of $25,598,089,216. Zimmer Biomet currently offers its equity investors a dividend that yields 0.8% per year.
The company is now trading -18.41% away from its average analyst target price of $150.15 per share. The 23 analysts following the stock have set target prices ranging from $120.0 to $172.0, and on average give Zimmer Biomet a rating of hold.
Over the last 52 weeks, ZBH stock has risen 3.0%, which amounts to a -7.0% difference compared to the S&P 500. The stock's 52 week high is $149.25 whereas its 52 week low is $102.6 per share. With its net margins declining an average -27.5% over the last 6 years, Zimmer Biomet may not have a strong enough profitability trend to support its stock price.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023-02-24 | 6,939,900 | 231,400 | 3 | -50.0 |
| 2022-02-25 | 6,827,300 | 401,600 | 6 | 400.0 |
| 2021-02-22 | 6,127,500 | -138,900 | -2 | -114.29 |
| 2020-02-21 | 7,982,200 | 1,131,600 | 14 | 380.0 |
| 2019-02-26 | 7,932,900 | -379,200 | -5 | -121.74 |
| 2018-02-27 | 7,803,300 | 1,813,800 | 23 |
